- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Sana to seek $150m in IPO
Three years after launching to commercialise stem cell research from Harvard University, Sana has filed for an initial public offering.
Jan 18, 2021Everactive nails down $35m
University of Michigan and Virginia-founded Everactive has reached its series C target after three tranches.
Jan 18, 2021Analysis: Interesting start for payment tech
The payment tech space saw a flurry of activity in mid-January with two series D rounds and an aborted acquisition at corporate-backed companies.
Jan 18, 2021Frontier IP selects Winter for corporate relationships role
Former senior sales director Darren Winter has joined Frontier IP to support its portfolio companies with fundraising.
Jan 15, 2021USF's Sanberg to return to faculty research
USF's senior vice-president for research and innovation Paul Sanberg will return to being a distinguished professor in neurosurgery and brain repair.
Jan 15, 2021SpyGlass observes $27.5m
The eye disease device developer has raised series B funding to advance research originating from University of Colorado's s Sue Anschutz-Rodgers Eye Center.
Jan 15, 2021SETsquared portfolio to pitch at GCV Digital Forum
Four of the incubator’s portfolio companies will pitch to investors at the GCV Digital Forum 3.0 following the success of similar competitions at our previous events.
Jan 14, 2021Lexeo stacks up $85m
Weill Cornell Medicine‘s monogenic diseases therapy developer Lexeo Therapeutics has made its public debut with $85m in series A financing.
Jan 13, 2021LifeMine Therapeutics lands $50m
LifeMine’s chairman and co-founder Rick Klausner has co-led a round that included multiple corporates and pushed the overall equity to $120m.
Jan 13, 2021LifeX Labs names Vardzel as president and CEO
Life sciences veteran Gerald J Vardzel has been named president and CEO of University of Pittsburgh’s LifeX Labs.
Jan 12, 2021Daily deal net: January 12, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jan 12, 2021Neural Galaxy detects pre-series A cash
The brain disease treatment developer was founded in 2019 on the back of more than a decade’s collaborative research from MIT and Harvard.
Jan 12, 2021Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
